研究目的
To prepare a miRNA137 biomimetic coated coronary stent by dual-injection four-beam laser interference for inhibiting postoperative restenosis.
研究成果
The miRNA137 biomimetic coated coronary stent prepared by the experiment has positive significance for inhibiting postoperative restenosis. The structured stent with the period of 3.077μm has superior adhesion and drug release properties to miRNA137 compared to other structures.
研究不足
The study does not mention the long-term effects of the stent in vivo or potential side effects.
1:Experimental Design and Method Selection:
A mutual injection dual-output solid-state laser was used as the light source to construct a four-beam interferometric processing system for micro-nano processing on the surface of the metal coronary stent.
2:Sample Selection and Data Sources:
The material is titanium alloy and the size is ¢3x25mm.
3:List of Experimental Equipment and Materials:
Mutual injection dual-output solid-state laser, beam splitters, coated mirrors, wave plates, polarizers, polyethylene glycol-lipid, miRNA
4:Experimental Procedures and Operational Workflow:
1 The stent was processed by the mutual injection four-beam interferometric processing system, then polyethylene glycol-lipid was fixed on the surface of the stent by electrostatic adsorption, and miRNA137 was assembled on polyethylene glycol layer.
5:Data Analysis Methods:
The drug-loading effect was tested by the adhesive method and the release performance of miRNA137 was tested by circulating in vitro simulated blood.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容-
mutual injection dual-output solid-state laser
Used as the light source to construct a four-beam interferometric processing system for micro-nano processing on the surface of the metal coronary stent.
-
beam splitters
Divides the laser beam into four beams.
-
coated mirrors
Condenses the laser beams onto the surface of the stent.
-
wave plates
Controls the intensity and polarization of the laser beams.
-
polarizers
Controls the intensity and polarization of the laser beams.
-
polyethylene glycol-lipid
Used as the carrier of miRNA137 to stably exist for a long time.
-
miRNA137
Used to inhibit postoperative restenosis.
-
登录查看剩余5件设备及参数对照表
查看全部